Lv5
900 积分 2023-05-20 加入
Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target
10天前
已完结
Novel Oligonucleotides Containing Two 3′-Ends Complementary to Target mRNA Show Optimal Gene-Silencing Activity
11天前
已完结
Context-dependent TGFβ family signalling in cell fate regulation
20天前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
24天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
24天前
已完结
Obesity and the risk of cardiometabolic diseases
1个月前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
1个月前
已完结
Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
1个月前
已完结
Genome-wide meta-analysis with 2,206,440 individuals identifies 322 novel risk loci for obesity
1个月前
已完结
Management of Medication-Induced Weight Gain
1个月前
已关闭
皖公网安备34019202002308
